NAD+: A key metabolic regulator with great therapeutic potential

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Dokumenter

  • Fulltext

    Accepteret manuskript, 289 KB, PDF-dokument

Nicotinamide adenine dinucleotide (NAD+) is a ubiquitous metabolite that serves an essential role in the catabolism of nutrients. Recently, there has been a surge of interest in NAD+ biology, with the recognition that NAD+ influences many biological processes beyond metabolism, including transcription, signalling and cell survival. There are a multitude of pathways involved in the synthesis and breakdown of NAD+, and alterations in NAD+ homeostasis have emerged as a common feature of a range of disease states. Here, we provide an overview of NAD+ metabolism and summarise progress on the development of NAD+-related therapeutics.

OriginalsprogEngelsk
Artikelnummere12508
TidsskriftJournal of Neuroendocrinology
Vol/bind29
Udgave nummer10
ISSN0953-8194
DOI
StatusUdgivet - 2017
Eksternt udgivetJa

Bibliografisk note

Publisher Copyright:
© 2017 British Society for Neuroendocrinology

ID: 322908691